Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 612 of 6351
-
New triple therapy aims to tame relapsed blood cancer
Disease control Recruiting nowTo learn if the drug combination pirtobrutinib, venetoclax, and obinutuzumab can help to control relapsed CLL/SLL.
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New implant aims to release trapped air in lungs of COPD patients
Disease control Recruiting nowThe objective of this study is to assess the safety and efficacy of Apreo BREATHE system when used to support native airways and release trapped air in the treatment of adult COPD patients with emphysema suffering from dyspnea due to hyperinflation despite optimal medical treatme…
Sponsor: Apreo Health, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Engineered immune cells take aim at stubborn blood cancers
Disease control Recruiting nowCAR-T cell treatment of refractory lymphoma has shown success, particularly with CD-19 targeted CAR-T cells, however, many participants are refractory or relapse after response. Responses are more limited in CLL/SLL, possibly secondary to the suppressive effect of circulating B c…
Phase 1 • Sponsor: Paolo Caimi, MD • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Gene therapy hope for kids and adults with rare Blindness-Causing mutation
Disease control Recruiting nowAdministering subretinal injection of LX107 injection (a gene therapy drug) to patients with retinal dystrophy caused by AIPL1 gene mutation to evaluate its efficacy and safety.
Early phase 1 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Can a simple inhaled antibiotic stop ventilator pneumonia?
Prevention Recruiting nowPrevious studies have identified Acinetobacter baumannii (AB), Pseudomonas aeruginosa (PA), and Klebsiella pneumoniae (KP) as the predominant pathogens responsible for ventilator-associated pneumonia (VAP). The challenge of drug resistance, especially against carbapenem is intens…
Sponsor: Qilu Hospital of Shandong University • Aim: Prevention
Last updated Jun 27, 2026 12:35 UTC
-
A simple gas flush before aortic repair might prevent strokes
Disease control Recruiting nowFlushTEVAR is a non-profit, interventional, randomized, controlled, single-blind, national multicenter study promoted by the University of Bologna and coordinated by the Vascular Surgery Unit of IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola, under…
Sponsor: University of Bologna • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Could a chat group boost diabetes care in seniors?
Disease control CompletedDiabetes mellitus is the ninth leading cause of mortality worldwide. Diabetes is a chronic condition with a major impact on the life and well-being of individuals, families, and societies globally. The three main types of diabetes are type 1 diabetes mellitus (T1DM), type 2 diabe…
Sponsor: Universiti Putra Malaysia • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New drug combo shows promise for Hard-to-Treat stomach cancer
Disease control Recruiting nowGastrointestinal stromal tumors (GISTs) are mostly driven by c-kit or PDGFRA mutations, and commonly occur in the stomach and small intestine. Targeted therapy is the mainstay for advanced metastatic GISTs, but there is a lack of effective regimens after drug resistance. Immune c…
Phase 2 • Sponsor: Jian Li • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Can a new injection help tackle obesity?
Disease control CompletedThis study is a randomized, double-blind, placebo-controlled, multiple-dose phase Ib clinical trial, aiming to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity characteristics of MWN109 injection in Chinese non-diabetic participants with ov…
Phase 1 • Sponsor: Shanghai Minwei Biotechnology Co., Ltd • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New drug aims to rescue platelet levels in leukemia patients
Disease control Recruiting nowEvaluation of the Efficacy and Safety of Romiplostim N01 for the Treatment of Cancer Treatment-Induced Thrombocytopenia (CTIT) in Patients with Leukemia
Phase 2 • Sponsor: Anhui Provincial Hospital • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New drug cocktail aims to shrink brain tumors in breast cancer patients
Disease control Recruiting nowThis study is a multicenter, two-stage clinical trial to evaluate the efficacy and safety of utidelone in combination with capecitabine in patients with HER2-negative breast cancer with brain metastases. Patients will be enrolled to receive treatment of utidelone alone or in comb…
Phase 2 • Sponsor: Biostar Pharma, Inc. • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
New drug combo aims to boost brain function in Alzheimer's patients
Symptom relief Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC for cognitive impairment in Alzheimer's Disease
Phase 3 • Sponsor: Bristol-Myers Squibb • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC
-
New device aims to safely drain fluid in heart failure patients
Disease control Recruiting nowThe objective of this study is to prospectively compare decongestive therapy administered by the Reprieve System to Optimal Diuretic Therapy (ODT) in the treatment of patients diagnosed with acute decompensated heart failure (ADHF). The main objective is to determine if the Repri…
Phase 3 • Sponsor: Reprieve Cardiovascular, Inc • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Knee surgery for Over-50s: does a specialized ACL technique match younger Patients' results?
Disease control Recruiting nowThe anterior cruciate ligament (ACL) is one of the main stabilizers of the knee, and its injury is among the most common soft tissue injuries of the knee. Surgical reconstruction of the ACL can be performed using various techniques and different types of tissue grafts, including …
Sponsor: Stefano Zaffagnini • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Which therapy restores hand function after stroke? a Head-to-Head trial
Disease control OngoingThis controlled clinical study investigates and compares the effectiveness of CIMT and TOT in improving hand function among post-stroke patients. A total of 48 participants from hospitals in Sialkot will be randomly divided into two groups and receive a 3-week intervention consis…
Sponsor: Riphah International University • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Less water, better lungs? new trial aims to protect preemies
Prevention Recruiting nowThe aim of this study is to determine whether restricted fluid intake (135 ±5 mL/kg/day) compared to liberal fluid intake (165 ±5 mL/kg/day) from day 8 of life reduces the incidence of bronchopulmonary dysplasia (BPD) at 36 weeks postmenstrual age or prior death in preterm infant…
Sponsor: University Children's Hospital Basel • Aim: Prevention
Last updated Jun 27, 2026 12:30 UTC
-
Engineered immune cells take on lupus in early trial
Disease control Recruiting nowA clinical study to explore the safety, efficacy and cell metabolic kinetics of universal CD19/20 car-t cell injection in moderate to severe refractory systemic lupus erythematosus. This study is a single arm, open, exploratory dose increasing clinical study, which aims to evalu…
Phase 1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New drug combo shows promise for Tough-to-Treat anal cancer
Disease control Recruiting nowThe purpose of this study is to gather information on the safety and effectiveness of lenvatinib combined with pembrolizumab in anal/rectal cancer that has spread to other parts of the body and will not respond to standard care.
Phase 2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Timing is everything: new trial aims to reduce transplant complications by adjusting when stem cells are given
Disease control Recruiting nowTo observe the effect of stem cell infusion on the development of acute graft- versus-host disease (aGVHD) in patients with malignant hematologic diseases after single-unit unrelated cord blood transplantation (sUCBT).
Phase 3 • Sponsor: Anhui Provincial Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New brain scanner could spot bleeding in minutes without radiation
Diagnosis Recruiting nowThe study population will consist of 3 mutually-exclusive sets of patients and subjects: * TBI patients with intracranial bleeding * TBI patients without intracranial bleeding * Control subjects with normal brain health. Research subjects ages 22 and older will be enrolled. All…
Sponsor: Sense Diagnostics, LLC • Aim: Diagnosis
Last updated Jun 27, 2026 07:59 UTC